Interleukin-2 and regulatory T cells
In the December 1st issue of the New England Journal of Medicine are two very interesting reports. The first from Koreth et al (2011; 365:2055-66) has studied the use of low dose interleukin-2 (IL-2) in chronic graft versus host disease following allogeneic haematopoietic stem cell transplantation for haematologic cancer that was resistant to steroid therapy. […]